✦ LIBER ✦

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

✍ Scribed by M. Nowicki; I. Rychlik; H. Haller; M. L. Warren; L. Suchower; I. Gause-Nilsson; for the D1680C00007 Investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improving glycaemic control self-efficac

✍ Qifang Shi; Sharon K Ostwald; Shaopeng Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

An audit of glycaemic control and cardio

✍ P. Downey; L. O’Shea; D. Dillon; M. Corbett; S. Sreenan 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 726 KB

Mosapride, a 5HT-4 receptor agonist, imp

✍ N. Ueno; A. Inui; A. Asakawa; F. Takao; Y. Komatsu; K. Kotani; R. Nishimura; M. 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 84 KB

Saxagliptin given in combination with me

✍ M. Jadzinsky; A. Pfützner; E. Paz-Pacheco; Z. Xu; E. Allen; R. Chen; CV181-039 I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB

An audit of glycaemic control and cardio

✍ P. Downey; L. O’Shea; D. Dillon; M. Corbett; S. Sreenan 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 250 KB

Lack of correlation between platelet rea

✍ Fabio Mangiacapra; Aaron J. Peace; William Wijns; Emanuele Barbato 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 182 KB